• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一份哮喘特异性生活质量问卷中,全球因素对患者可感知变化的影响。

Impact of the global on patient perceivable change in an asthma specific QOL questionnaire.

作者信息

Barber B L, Santanello N C, Epstein R S

机构信息

Department of Health Economic Statistics, Merck Research Laboratories, West Point, PA, USA.

出版信息

Qual Life Res. 1996 Feb;5(1):117-22. doi: 10.1007/BF00435976.

DOI:10.1007/BF00435976
PMID:8901374
Abstract

One method of defining clinically meaningful changes in quality of life domain scores is 'anchoring', that is, relating changes in domain scores to more easily understood changes on a global question. Although this methodology has been used to assess changes in domain scores in clinical trials, the choice of global question has not undergone much scrutiny. This study examines the impact of two global questions on the definition of clinically meaningful changes in an asthma specific quality of life (ASQOL) questionnaire. We tracked 343 patients with mild to moderate asthma symptoms in a placebo controlled clinical trial. The patients responded to the ASQOL questionnaire, and answered two global questions; one assessing how well their asthma is controlled, and the other assessing the change in their asthma since the start of the study. Changes in each domain of the ASQOL questionnaire were related to each global question. Since each global question led to different definitions of what constituted meaningful change, we concluded that the wording of the global question can affect the definition of meaningful change in the ASQOL domain scores. Thus, when identifying meaningful changes, it is important to state the global question so that the context of the meaningful change is correctly understood.

摘要

定义生活质量领域得分中具有临床意义的变化的一种方法是“锚定”,即把领域得分的变化与一个更易于理解的整体问题上的变化联系起来。尽管这种方法已被用于评估临床试验中领域得分的变化,但整体问题的选择并未受到太多审视。本研究考察了两个整体问题对哮喘特异性生活质量(ASQOL)问卷中具有临床意义的变化的定义的影响。我们在一项安慰剂对照临床试验中跟踪了343名有轻度至中度哮喘症状的患者。患者对ASQOL问卷做出回应,并回答了两个整体问题;一个评估他们的哮喘控制得如何,另一个评估自研究开始以来他们哮喘的变化。ASQOL问卷各领域的变化与每个整体问题相关。由于每个整体问题导致了对构成有意义变化的不同定义,我们得出结论,整体问题的措辞会影响ASQOL领域得分中有意义变化的定义。因此,在确定有意义的变化时,说明整体问题很重要,以便正确理解有意义变化的背景。

相似文献

1
Impact of the global on patient perceivable change in an asthma specific QOL questionnaire.在一份哮喘特异性生活质量问卷中,全球因素对患者可感知变化的影响。
Qual Life Res. 1996 Feb;5(1):117-22. doi: 10.1007/BF00435976.
2
Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.布地奈德吸入混悬液与色甘酸钠雾化溶液对儿童哮喘健康状况及照顾者生活质量影响的比较
Pediatrics. 2003 Sep;112(3 Pt 1):e212-9. doi: 10.1542/peds.112.3.e212.
3
[Utilization and clinical validation of the Spanish version of the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) and the Diary for Caregivers of Asthmatic Children (DCA). VALAIR study].[儿童哮喘生活质量问卷(PAQLQ)西班牙语版及哮喘儿童照顾者日记(DCA)的应用与临床验证。VALAIR研究]
Allergol Immunopathol (Madr). 2000 May-Jun;28(3):175-83.
4
The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life of adult asthma patients.一种含有γ-亚麻酸和二十碳五烯酸的医用食品对成人哮喘患者哮喘管理及生活质量的影响。
Curr Med Res Opin. 2008 Feb;24(2):559-67. doi: 10.1185/030079908x273011.
5
Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care.通过药学服务评估哮喘生活质量问卷的反应性。
Pharm World Sci. 2008 Aug;30(4):322-8. doi: 10.1007/s11096-007-9179-y. Epub 2007 Nov 16.
6
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.孟鲁司特,一种白三烯受体拮抗剂,用于治疗2至5岁儿童的持续性哮喘。
Pediatrics. 2001 Sep;108(3):E48. doi: 10.1542/peds.108.3.e48.
7
Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial.早期哮喘预防、自然病史、骨骼发育与经济(EASE):一项随机对照试验试点研究
Health Technol Assess. 2000;4(28):1-89.
8
Improvement in quality of life with omalizumab in patients with severe allergic asthma.奥马珠单抗改善重度过敏性哮喘患者的生活质量。
Curr Med Res Opin. 2006 Nov;22(11):2201-8. doi: 10.1185/030079906X148643.
9
An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials.在糠酸莫米松/富马酸福莫特罗临床试验中对持续性哮喘青少年和成人的哮喘控制变化评估。
J Asthma. 2011 Feb;48(1):48-56. doi: 10.3109/02770903.2010.529220. Epub 2010 Nov 1.
10
Validation and agreement across four versions of the asthma control questionnaire in patients with persistent asthma.四种版本哮喘控制问卷在持续性哮喘患者中的验证和一致性。
Respir Med. 2011 May;105(5):698-712. doi: 10.1016/j.rmed.2010.11.004. Epub 2010 Dec 10.

引用本文的文献

1
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.随机对照试验中目标差值的指定方法:试验差值 elicitation(DELTA)系统评价。
PLoS Med. 2014 May 13;11(5):e1001645. doi: 10.1371/journal.pmed.1001645. eCollection 2014 May.
2
Patient reports of the outcomes of treatment: a structured review of approaches.患者对治疗结果的报告:方法的系统评价。
Health Qual Life Outcomes. 2014 Jan 14;12:5. doi: 10.1186/1477-7525-12-5.
3
Estimating clinically significant differences in quality of life outcomes.

本文引用的文献

1
Measuring quality of life in asthma.哮喘患者生活质量的测量
Am Rev Respir Dis. 1993 Apr;147(4):832-8. doi: 10.1164/ajrccm/147.4.832.
2
Interpretation of quality of life changes.生活质量变化的解读。
Qual Life Res. 1993 Jun;2(3):221-6. doi: 10.1007/BF00435226.
3
Performance of an asthma quality of life questionnaire in an outpatient setting.哮喘生活质量问卷在门诊环境中的表现
评估生活质量结果中具有临床意义的差异。
Qual Life Res. 2005 Mar;14(2):285-95. doi: 10.1007/s11136-004-0705-2.
4
Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report.慢性阻塞性肺疾病患者健康相关生活质量的临床重要变化:专家共识小组报告
J Gen Intern Med. 2003 Mar;18(3):196-202. doi: 10.1046/j.1525-1497.2003.20203.x.
5
Responsiveness of the quality of life in epilepsy inventory (QOLIE-89) in an antiepileptic drug trial.抗癫痫药物试验中癫痫生活质量量表(QOLIE - 89)的反应性
Qual Life Res. 2003 Mar;12(2):147-55. doi: 10.1023/a:1022209105926.
6
The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?
Pharmacoeconomics. 2000 Nov;18(5):419-23. doi: 10.2165/00019053-200018050-00001.
7
Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample.美国样本中哮喘生活质量问卷的心理测量学表现。
Qual Life Res. 1998 Feb;7(2):127-34. doi: 10.1023/a:1008853325724.
Am Rev Respir Dis. 1993 Sep;148(3):675-81. doi: 10.1164/ajrccm/148.3.675.
4
Determining a minimal important change in a disease-specific Quality of Life Questionnaire.确定特定疾病生活质量问卷中的最小重要变化。
J Clin Epidemiol. 1994 Jan;47(1):81-7. doi: 10.1016/0895-4356(94)90036-1.
5
The significance of treatment effects: the clinical perspective.治疗效果的意义:临床视角。
Med Care. 1995 Apr;33(4 Suppl):AS286-91.
6
Quantification of agreement in psychiatric diagnosis. A new approach.精神科诊断一致性的量化:一种新方法。
Arch Gen Psychiatry. 1967 Jul;17(1):83-7. doi: 10.1001/archpsyc.1967.01730250085012.
7
Measurement of health status. Ascertaining the minimal clinically important difference.健康状况的测量。确定最小临床重要差异。
Control Clin Trials. 1989 Dec;10(4):407-15. doi: 10.1016/0197-2456(89)90005-6.
8
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.哮喘患者健康相关生活质量损害的评估:用于临床试验的问卷编制
Thorax. 1992 Feb;47(2):76-83. doi: 10.1136/thx.47.2.76.